William H. Riffee

736 total citations
35 papers, 616 citations indexed

About

William H. Riffee is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, William H. Riffee has authored 35 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in William H. Riffee's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). William H. Riffee is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). William H. Riffee collaborates with scholars based in United States. William H. Riffee's co-authors include Richard E. Wilcox, Robert V. Smith, Michael C. Gerald, Adam M. Persky, Diane E. Beck, Charles Green, Gary M. Pollack, Robert A. Blouin, P. U. Joyner and Dana M. Vaughn and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

William H. Riffee

34 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Riffee United States 16 314 178 116 75 63 35 616
David R. Bristow United Kingdom 18 566 1.8× 522 2.9× 40 0.3× 138 1.8× 44 0.7× 42 971
Debra L. Yourick United States 17 270 0.9× 190 1.1× 83 0.7× 53 0.7× 88 1.4× 32 760
I E Hughes United Kingdom 12 195 0.6× 202 1.1× 85 0.7× 20 0.3× 31 0.5× 53 538
Amber V. Buhler United States 14 414 1.3× 460 2.6× 43 0.4× 54 0.7× 27 0.4× 24 793
Tina Hinton Australia 15 139 0.4× 140 0.8× 76 0.7× 45 0.6× 16 0.3× 34 562
Michael A. Fauman United States 13 91 0.3× 139 0.8× 37 0.3× 17 0.2× 119 1.9× 29 570
Colin OʼGara United Kingdom 13 132 0.4× 124 0.7× 19 0.2× 50 0.7× 77 1.2× 31 574
Hongxian Chen China 17 189 0.6× 106 0.6× 60 0.5× 29 0.4× 40 0.6× 36 749
Fernanda Costa Nunes Brazil 14 204 0.6× 155 0.9× 17 0.1× 27 0.4× 68 1.1× 60 703
Maressa Hecht Orzack United States 15 109 0.3× 44 0.2× 73 0.6× 36 0.5× 314 5.0× 21 847

Countries citing papers authored by William H. Riffee

Since Specialization
Citations

This map shows the geographic impact of William H. Riffee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Riffee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Riffee more than expected).

Fields of papers citing papers by William H. Riffee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Riffee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Riffee. The network helps show where William H. Riffee may publish in the future.

Co-authorship network of co-authors of William H. Riffee

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Riffee. A scholar is included among the top collaborators of William H. Riffee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Riffee. William H. Riffee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blouin, Robert A., William H. Riffee, Diane E. Beck, et al.. (2009). Roles of Innovation in Education Delivery. American Journal of Pharmaceutical Education. 73(8). 154–154. 112 indexed citations
2.
Blouin, Robert A., William H. Riffee, Diane E. Beck, et al.. (2009). AACP CURRICULAR CHANGE SUMMIT SUPPLEMENT Roles of Innovation in Education Delivery. 11 indexed citations
3.
Nahata, Milap C., et al.. (2003). AACP Reports: Report of the 2002/2003 Finance Committee. American Journal of Pharmaceutical Education. 67(3). 1–7. 57 indexed citations
4.
Riffee, William H.. (2002). Globalization: The Exportation of Higher Education.. 15(12). 18–20. 1 indexed citations
5.
Riffee, William H., et al.. (1995). Computers in the Classroom: A New Form of Active Learning. American Journal of Pharmaceutical Education. 59(1). 1–7. 9 indexed citations
6.
Riffee, William H.. (1991). Computer Technology Can Enhance Presentation of Pharmacological Principles. American Journal of Pharmaceutical Education. 55(2). 148–152. 2 indexed citations
7.
Riffee, William H., et al.. (1990). Views of Former Students on Interactive Television and Videotapes as Forms of Instruction. American Journal of Pharmaceutical Education. 54(2). 120–125. 3 indexed citations
8.
Vaughn, Dana M., James A. Severson, John J. Woodward, et al.. (1990). Behavioral sensitization following subchronic apomorphine treatment — possible neurochemical basis. Brain Research. 526(1). 37–44. 18 indexed citations
9.
Wilcox, Richard E., James A. Severson, John J. Woodward, et al.. (1990). Behavioral sensitization following a single apomorphine pretreatment — selective effects on the dopamine release process. Brain Research. 528(1). 109–113. 6 indexed citations
10.
Riffee, William H., et al.. (1988). Apomorphine fails to inhibit cocaine-induced behavioral hypersensitivity. Pharmacology Biochemistry and Behavior. 29(2). 239–242. 8 indexed citations
11.
Riffee, William H., et al.. (1987). Prevention of amphetamine-induced behavioral hypersensitivity by concomitant treatment with microgram doses of apomorphine. European Journal of Pharmacology. 135(2). 255–258. 5 indexed citations
12.
Woodward, John J., Richard E. Wilcox, Steven W. Leslie, & William H. Riffee. (1986). Dopamine uptake during fast-phase endogenous dopamine release from mouse striatal synaptosomes. Neuroscience Letters. 71(1). 106–112. 19 indexed citations
13.
Wilcox, Richard E., et al.. (1984). Effects of ascorbate on a dopaminergic response: Apomorphine-induced modification of pentylenetetrazol-induced seizures in mice. Psychopharmacology. 83(1). 48–50. 3 indexed citations
14.
Riffee, William H., et al.. (1981). Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice. Psychopharmacology. 75(4). 391–395. 7 indexed citations
15.
Wilcox, Richard E., et al.. (1980). Behavioral facilitation following chronic administration of N-n-propylnorapomorphine. Psychopharmacology. 72(1). 113–115. 22 indexed citations
16.
Wilcox, Richard E., Robert V. Smith, Julie A. Anderson, & William H. Riffee. (1980). Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity. Pharmacology Biochemistry and Behavior. 12(1). 29–33. 40 indexed citations
17.
Wilcox, Richard E., William H. Riffee, & Robert V. Smith. (1980). Hypothermic effects of N-n-propylnorapomorphine in mice: Antagonism by neurotransmitter receptor blockers. Psychopharmacology. 68(1). 85–88. 1 indexed citations
18.
Riffee, William H., Richard E. Wilcox, Julie A. Anderson, & James W. McGinity. (1980). Polydimethylsiloxane pellets for sustained delivery of morphine in mice. Journal of Pharmaceutical Sciences. 69(8). 980–982. 6 indexed citations
19.
Riffee, William H., Richard E. Wilcox, & Robert V. Smith. (1979). Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice. European Journal of Pharmacology. 54(3). 273–277. 21 indexed citations
20.
Riffee, William H., Thomas M. Ludden, Richard E. Wilcox, & Michael C. Gerald. (1978). Brain and plasma concentrations of amphetamine isomers in mice.. Journal of Pharmacology and Experimental Therapeutics. 206(3). 586–594. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David R. Bristow Breakdown of academic impact, for papers by Debra L. Yourick Breakdown of academic impact, for papers by I E Hughes Breakdown of academic impact, for papers by Amber V. Buhler Breakdown of academic impact, for papers by Tina Hinton Breakdown of academic impact, for papers by Michael A. Fauman Breakdown of academic impact, for papers by Colin OʼGara Breakdown of academic impact, for papers by Hongxian Chen Breakdown of academic impact, for papers by Fernanda Costa Nunes Breakdown of academic impact, for papers by Maressa Hecht Orzack
Rankless by CCL
2026